Synergic activity of selenium and probiotic bacterium Enterococcus faecium M-74 against selected mutagens in Salmonella assay

Folia Microbiologica

Volumn 49, Issue 3, 2004, Pages 301-305

  Belicova A ^a   Krizkova L ^a   Dobias, J ^a   Krajcovic J ^a   Ebringer, L ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 2942534960     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931047     Document Type: Article

References (47)

1. ANNUK H., SHCHEPETOVA J., KULLISAAR T., SONGISEPP E., ZILMER M., MIKELSAAR M.: Characterization of intestinal lactobacilli as putative probiotic candidates. J. Appl. Microbiol. 94, 403-412 (2003).
2. ASHAR M.N., PRAJAPATI J.B.: Verification of hypocholesterolemic effect of fermented milk on human subjects with different cholesterol levels. Folia Microbiol. 45, 263-268 (2000).
3. BANSAL M.P., KAUR T.: Growth characteristics and selenium status changes of yeast cells with inorganic and organic selenium supplementation: selenium, a chemopreventive agent. J. Med. Food 5, 85-90 (2002).
4. BELICOVÁ A., KRAJČOVIČ J., DOBIAS J., EBRINGER L.: Antimutagenicity of milk fermented by Enterococcus faecium. Folia Microbiol. 44, 513-518 (1999).
5. BENYACOUB J., CZARNECKI-MAULDEN G.L., CAVADINI C., SAUTHIER T., ANDERSON R.E., SCHIFFRIN E.J., VON DER WEID T.: Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs. J. Nutr. 133, 1158-1162 (2003).
6. CASES J., VACCHINA V., NAPOLITANO A., CAPORICCIO B., BESANCON P., LOBINSKI R., ROUANET J.M.: Selenium from selenium-rich Spirulina is less bioavailable than selenium from sodium selenite and selenomethionine in selenium-deficient rats. J. Nutr. 131, 2343-2350 (2001).
7. CHIN-THIN W., WEI-TUN C., TZU-MING P., REN-TSE W.: Blood concentrations of selenium, zinc, iron, copper and calcium in patients with hepatocellular carcinoma. Clin. Chem. Lab. Med. 40, 1118-1122 (2002).
8. EBRINGER L., FERENČÍK M., LAHITOVÁ N., KAČÁNI L., MICHÁLKOVÁ D.: Anti-mutagenic and immuno-stimulatory properties of lactic acid bacteria. World J. Microbiol. Biotechnol. 11, 294-298 (1995).
9. EBRINGER L., DOBIAS J., KRAJČOVIČ J., POLÓNYI J., KRIŽKOVÁ L., LAHITOVÁ N.: Antimutagens reduce ofloxacin-induced bleaching in Euglena gracilis. Mutat. Res. 359, 85-93 (1996).
10. FERENČÍK M., EBRINGER L.: Modulatory effects of selenium and zinc on the immune system. Folia Microbiol. 48, 417-426 (2003).
11. FINLEY J.W.: Reduction of cancer risk by consumption of selenium-enriched plants: enrichment of broccoli with selenium increases the anticarcinogenic properties of broccoli. J. Med. Food 6, 19-26 (2003).
12. HRUBÝ S., ŠPELINA V., SCHLEMMEROVÁ A.: The significance of the consumption of specifically fermented dairy products for the composition of the intestinal microflora and for serum cholesterol values. Českoslov. Hyg. 37, 109-114 (1992).
13. IP C., EL-BAYOUMY K., UPADHAYA P., GANTHER H., VADHANAVIKIT S., THOMPSON H.J.: Comparative effect of inorganic and organic selenocyanate derivatives in cancer chemoprevention. Carcinogenesis 15, 187-192 (1994).
14. JACOBSEN C.N., ROSENFELDT., NIELSEN V., HAYFORD A.E., MOLLER P.L., MICHAELSEN K.F., PAERREGAARD A., SANDSTROM B., TVEDE M., JAKOBSEN M.: Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl. Environ. Microbiol. 65, 4949-4956 (1999).
15. JIAN S.W., MEI C.E., LIANG Y.N., LI D., CHEN Q.L., LUO H.L., LI Y.Q., CAI T.Y.: Influence of selenium-rich rice on transformation of umbilical blood B lymphocytes by Epstein-Barr virus and Epstein-Barr virus early-antigen expression. Ai Zheng 22, 26-29 (2003).
16. JIN L.Z., MARQUARDT R.R., ZHAO X.: A strain of Enterococcus faecium (18C23) inhibits adhesion of enterotoxigenic Escherichia coli K88 to porcine small intestine mucus. Appl. Environ. Microbiol. 66, 4200-4204 (2000).
17. KAILA M., ISOLAURI E., SOPPI E., VIRTANEN E., LAINE S., ARVILOMMI H.: Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res. 32, 141-144 (1992).
18. KLEIN E.A., THOMPSON I.M., LIPPMAN S.M., GOODMAN P.J., ALBANES D., TAYLOR P.R., COLTMAN C.: SELECT: the selenium and vitamin E cancer prevention trial. Urol. Oncol. 21, 59-65 (2003).
19. KOS B., ŠUŠKOVIĆ J., GORETA J., MATOŠ IĆ S.: Effect of protectors on the viability of Lactobacillus acidophilus M92 in simulated gastrointestinal conditions. Food Technol. Biotechnol. 38, 121-128 (2000).
20. KRIŽKOVÁ L., HORNIAK L., SLÁVIKOVÁ S., EBRINGER L.: Protective effects of sodium selenite on ofloxacin-induced loss of chloroplast DNA in Euglena gracilis. Folia Microbiol. 41, 329-332 (1996).
21. KRIŽKOVÁ L., BELICOVÁ A., DOBIAS J., KRAJČOVIČ J., EBRINGER L.: Selenium enhances the antimutagenic activity of probiotic bacterium Enterococcus faecium M-74. World J. Microbiol. Biotechnol. 18, 867-873 (2002).
22. KULLISAAR T., ZILMER M., MIKELSAAR M., VIHALEMM T., ANNUK H., KAIRANE C., KILK A.: Two antioxidative lactobacilli strains as promising probiotics. Internat. J. Food Microbiol. 72, 215-224 (2002).
23. LANKAPUTHRA W.E.V., SHAH N.P.: Antimutagenic properties of probiotic bacteria and of organic acids. Mutat. Res. 397, 169-182 (1998).
24. LAUKOVÁ A., CZIKKOVÁ S., BURDOVÁ O.: Anti-staphylococcal effect of enterocin in Sunar and yogurt. Folia Microbiol. 44, 707-711 (1999).
25. LEWENSTEIN A., FRIGERIO G., MORONI M.: Biological properties of SF68, a new approach for the treatment of diarrhoeal diseases. Curr. Ther. Res. 26, 967-981 (1979).
26. LI Z.Y., GUO S.Y., LI L.: Bioeffects of selenite on the growth of Spirulina platensis and its biotransformation. Biores. Technol. 89, 171-176 (2003).
27. LOGUERCIO C., ABBIATI R., RINALDI M., ROMANO A., DEL VECCHIO BLANCO C., COLTORTI M.: Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. J. Hepatol. 23, 39-46 (1995).
28. LOPEZ-SAEZ J.B., SENRA-VARELA A., POUSA-ESTEVEZ L.: Selenium in breast cancer. Oncology 64, 227-231 (2003).
29. LU J., PEI H., IP C., LISK D.J., GANTHER H., THOMPSON H.J.: Effect of an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis 17, 1903-1907 (1996).
30. MARON D.M., AMES B.N.: Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113, 173-215 (1983).
31. MIKEŠ Z., FERENČÍK M., JAHNOVÁ E., EBRINGER L., ČIŽNÁR I.: Hypocholesterolemic and immunostimulatory effects of orally applied Enterococcus faecium M-74 in man. Folia Microbiol. 40, 639-646 (1995).
32. NADATHUR S.R., GOULD S.J., BAKALINSKY A.T.: Antimutagenicity of an acetone extract of yogurt. Mutat. Res. 334, 213-224 (1995).
33. OLASUPO N.A.: Inhibition of Listeria monocytogenes by plantaricin NA, an antibacterial substance from Lactobacillus plantarum. Folia Microbiol. 43, 151-155 (1998).
34. ORRHAGE K., SILLERSTROM E., GUSTAFSSON J.A., NORD C.E., RAFTER J.: Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat. Res. 311, 239-248 (1994).
35. OSUNTOKI A.A., GBENLE G.O., OLUKOYA D.K.: Evidence for chromosomal determination of fungicidal activity in strains of Lactobacillus brevis and Lactobacillus fermentum isolated from fermented foods. Folia Microbiol. 48, 56-58 (2003).
36. PANTEV A., KABADJOVA P., DALGALARRONDO M., HAERTLÉ T., IVANOVA I., DOUSSET X., PRÉVOST H., CHOBERT J.-M.: Isolation and partial characterization of an antibacterial substance produced by Enterococcus faecium. Folia Microbiol. 47, 391-400 (2002a).
37. PANTEV A., KABADJOVA P., VALCHEVA R., DANOVA S., DOUSSET X., HAERTLÉ T., CHOBERT J.-M., IVANOVA I.: Effects of nitrogen sources on bacteriocin production by Enterococcus faecium A-2000. Folia Microbiol. 47, 659-662 (2002b).
38. ROVENSKÝ J., ŠVÍK K., STANČÍ KOVÁ M., IŠTÓK R., EBRINGER L., FERENČÍK M.: Treatment of experimental adjuvant arthritis with the combination of methotrexate and lyophilized Enterococcus faecium enriched with organic selenium. Folia Microbiol. 47, 573-578 (2002).
39. SAARELA M., MOGENSEN G., FONDEN R., MATTO J., MATTILA-SANDHOLM T.: Probiotic bacteria: safety, functional and technological properties. J. Biotechnol. 84, 197-215 (2000).
40. SALMINEN S., OUWEHAND A.C., BENNO Y., LEE Y.K.: Probiotics: how should they be defined. Trends Foods Sci. Technol. 10, 107-110 (1999).
41. SCHIFFRIN E.J., ROCHAT F., LINK-AMSTER H., AESCHLIMANN J.M., DONNET-HUGHES A.: Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 78, 491-497 (1995).
42. SHUKLA V.K., ADUKIA T.K., SINGH S.P., MISHRA C.P., MISHRA R.N.: Micronutrients, antioxidants, and carcinoma of the gallbladder. J. Surg. Oncol. 84, 31-35 (2003).
43. ŠUŠKOVIĆ J., KOS B., MATOŠIĆ S., BESENDORFER V.: The effect of bile salts on survival and morphology of a potential probiotic strain Lactobacillus acidophilus M92. World J. Microbiol. Biotechnol. 16, 673-678 (2000).
44. VANČÍKOVÁ Z., LODINOVÁ- ŽÁDNÍKOVÁ R., RADL J., TLASKALOVÁ- HOGENOVÁ H.: The early postnatal development of salivary antibody and immunoglobulin response in children orally colonized with a nonpathogenic, probiotic strain of E. coli. Folia Microbiol. 48, 281-288 (2003).
45. VOGT T.M., ZIEGLER R.G., GRAUBARD B.I., SWANSON C.A., GREENBERG R.S., SCHOENBERG J.B., SWANSON G.M., HAYES R.B., MAYNE S.T.: Serum selenium and risk of prostate cancer in US blacks and whites. Internat. J. Cancer 103, 664-670 (2003).
46. WOJTCZAK A.: Selenium as an anticancerogenic agent. Acta Polon. Pharm. 60, 215-217 (2003).
47. WUNDERLICH P.F., BRAUN L., FUMAGALLI I., D'APUZZO V., HEIM F., KARLY M., LODI R., POLITTA G., VONBANK F., ZELTNER L.: Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhea and in the treatment of acute diarrhea. J. Internat. Med. Res. 17, 333-338 (1989).